💡 What You Need to Know Right Away
- Highly Accurate Test: The combined creatinine-cystatin C equation achieves 94.9% accuracy when compared to measured GFR, the gold standard.[Evidence: A][4]
- CKD Definition: A GFR below 60 mL/min/1.73m² lasting more than 3 months indicates chronic kidney disease (CKD).[Evidence: D][2]
- Prognostic Value: A rapid GFR decline greater than 5 mL/min per year predicts higher risk of end-stage renal disease (ESRD) and mortality.[Evidence: C][6]
- Screening Effectiveness: In high-risk patients with diabetes or hypertension, point-of-care eGFR testing detects 38.8% previously undiagnosed CKD cases.[Evidence: C][8]
If you have received kidney test results and feel confused by terms like "GFR" or "eGFR," you are not alone. Many people find themselves anxious after seeing numbers they do not fully understand. This guide will help you make sense of your results.
Glomerular filtration rate (GFR) is a blood test that measures how well your kidneys filter waste from your blood. It is the most important marker doctors use to assess kidney health and diagnose chronic kidney disease. Understanding your GFR can help you take control of your kidney health and know when to seek medical attention.
In this comprehensive guide, you will learn what GFR measures, how to interpret your results, what the different CKD stages mean, and evidence-based steps you can take to protect your kidneys. Whether you are monitoring an existing condition or simply want to understand a routine test result, this information will help you have more informed conversations with your healthcare provider.
❓ Quick Answers
What is GFR (Glomerular Filtration Rate)?
GFR measures the volume of blood your kidneys filter per minute. It is expressed in milliliters per minute per 1.73 square meters of body surface area (mL/min/1.73m²). Doctors use GFR as the primary test for assessing kidney function and diagnosing chronic kidney disease. The estimated GFR (eGFR) is recommended for initial kidney assessment due to its 90-95% specificity for CKD classification.[Evidence: B][1]
What is a normal GFR level?
A normal GFR is typically 90 mL/min/1.73m² or higher in healthy young adults. GFR naturally declines with age, decreasing approximately 1 mL/min per year after age 40. According to KDIGO 2024 guidelines, an eGFR below 60 mL/min/1.73m² persisting for more than 3 months indicates chronic kidney disease.[Evidence: D][2]
How is GFR calculated?
GFR is estimated using the CKD-EPI 2021 equation, which uses your blood creatinine level, age, and sex. This race-free equation maintains 92-97% accuracy for detecting CKD.[Evidence: C][3] The equation is: eGFR = 142 × min(SCr/κ, 1)^α × max(SCr/κ, 1)^-1.200 × 0.9938^Age × 1.012 [if female]. Your laboratory calculates this automatically from your creatinine blood test.
What do GFR results mean for kidney disease staging?
GFR results determine your CKD stage: Stage 1 (eGFR ≥90 with kidney damage), Stage 2 (eGFR 60-89), Stage 3a (eGFR 45-59), Stage 3b (eGFR 30-44), Stage 4 (eGFR 15-29), and Stage 5 (eGFR below 15, kidney failure). Early stages often have no symptoms, making regular testing important for those at risk.[Evidence: D][2]
When should I see a doctor for low GFR?
See your doctor if your eGFR falls below 60 mL/min/1.73m² on two tests three months apart. Seek urgent referral to a nephrologist if eGFR drops below 30, declines rapidly (more than 5 mL/min per year), or you develop symptoms like persistent fatigue, swelling, or changes in urination. Point-of-care screening detects 38.8% of CKD cases in high-risk populations with diabetes or hypertension.[Evidence: C][8]
What is the difference between eGFR and measured GFR?
Estimated GFR (eGFR) is calculated from blood creatinine using equations and is used for routine clinical care. Measured GFR (mGFR) uses tracer substances like iohexol and is the gold standard but rarely needed. The combined creatinine-cystatin C equation achieves 94.9% P30 accuracy compared to measured GFR.[Evidence: A][4]
Glomerular Filtration Rate
Understanding GFR is essential for assessing kidney health. It estimates how much blood passes through the glomeruli each minute, serving as the primary indicator for kidney function and staging disease.
🔬 How Your Kidneys Filter Blood
Your kidneys work like sophisticated water treatment plants, processing approximately 180 liters of blood every day. Each kidney contains about one million tiny filtering units called nephrons. At the center of each nephron is the glomerulus, a cluster of tiny blood vessels where the actual filtration occurs.
Think of each glomerulus as a coffee filter. Just as a coffee filter allows water and dissolved substances to pass through while holding back the coffee grounds, your glomeruli filter waste products and excess fluid from your blood while keeping essential proteins and blood cells where they belong. When these filters become damaged, waste builds up in your blood and protein may leak into your urine.
The glomerular filtration rate measures how efficiently this filtering process works. A healthy adult's kidneys filter blood at a rate of 90-120 mL per minute. Blood enters the glomerulus under pressure, forcing fluid and small molecules through the filter membrane. This filtered fluid, called filtrate, then passes through the tubules where your body reabsorbs needed substances like glucose and minerals while concentrating the waste as urine.
Several factors affect GFR. The creatinine-based equations used to estimate GFR account for age, sex, and muscle mass. However, research confirms that combined creatinine-cystatin C measurements achieve 94.9% P30 accuracy (meaning the estimate falls within 30% of the true measured GFR), compared to 92.1% for creatinine alone.[Evidence: A][4] Cystatin C-based equations show improved accuracy in specific populations including those with HIV, cancer, or obesity.[Evidence: A][10]
The CKD-EPI 2021 equation represents the current standard for estimating GFR. This race-free equation replaced earlier versions that included a race coefficient, recognizing that race is a social construct rather than a biological variable affecting kidney function. Validation studies confirm the 2021 equation maintains 92-97% accuracy for CKD detection across diverse populations.[Evidence: C][3]
📊 Understanding Your GFR Results
Your GFR result tells you which stage of kidney function you are in. The table below shows the five stages of chronic kidney disease based on GFR, what each stage means for your kidney health, and the recommended actions.
| CKD Stage | eGFR Range (mL/min/1.73m²) | Kidney Function | Typical Symptoms | Recommended Action |
|---|---|---|---|---|
| Stage 1 | ≥90 (with kidney damage markers) | Normal or high | Usually none | Monitor annually, control risk factors[2] |
| Stage 2 | 60-89 | Mildly decreased | Usually none | Monitor annually, manage blood pressure[2] |
| Stage 3a | 45-59 | Mildly to moderately decreased | Often none; may have fatigue | Monitor every 6 months, consider nephrology referral[2] |
| Stage 3b | 30-44 | Moderately to severely decreased | Fatigue, swelling may appear | Nephrology referral, medication review[2] |
| Stage 4 | 15-29 | Severely decreased | Fatigue, nausea, swelling, itching | Urgent nephrology care, prepare for dialysis/transplant[2] |
| Stage 5 | <15 | Kidney failure | Severe symptoms; uremic symptoms | Dialysis or kidney transplant needed[2] |
Interpreting eGFR Accuracy
Your eGFR result is an estimate, not an exact measurement. The eGFR-C study, a comprehensive meta-analysis, confirmed that creatinine-based eGFR achieves P30 accuracy of 92.1%, meaning the estimate falls within 30% of the true measured GFR in over 9 out of 10 cases.[Evidence: A][4] For most clinical decisions, this level of accuracy is sufficient.
When higher precision is needed, your doctor may order the combined creatinine-cystatin C test, which achieves 94.9% P30 accuracy.[Evidence: A][4] The 2024 KDIGO guidelines recommend this combined approach for confirmatory testing.[Evidence: D][2]
Understanding GFR Decline
A single GFR reading provides a snapshot. The rate of change over time often matters more than any single number. Research shows that an eGFR decline greater than 15% is associated with higher risk of adverse kidney outcomes.[Evidence: B][5] Tracking your GFR over multiple tests helps identify trends.
The DISCOVER CKD cohort study, following patients for over 12 years, found that rapid decline exceeding 5 mL/min per year predicts significantly higher risk of progressing to end-stage renal disease requiring dialysis.[Evidence: C][6] Patients with non-rapid decline showed substantially better long-term outcomes.
⚠️ Limitations and Special Considerations
When eGFR May Be Less Accurate
Several factors can affect creatinine levels independent of actual kidney function. Recent consumption of cooked meat can temporarily raise creatinine. Certain medications including cimetidine and trimethoprim can increase creatinine levels without affecting true GFR. Extreme hydration states also influence results.
For individuals where creatinine-based eGFR may be unreliable, cystatin C provides an alternative biomarker. A systematic review confirmed that cystatin C-based eGFR shows improved accuracy in patients with HIV, cancer, and obesity, with the combined equation providing 7.50% better accuracy than creatinine alone in these populations.[Evidence: A][10]
Understanding Prognostic Significance
GFR provides important information about long-term health risks. The Tehran Lipid and Glucose Study, following over 2,200 participants for more than a decade, found that each 10 mL/min decline in GFR was associated with a 15% increase in all-cause mortality (hazard ratio 1.15, 95% CI: 1.04-1.26).[Evidence: C][7]
However, context matters. In blood pressure treatment trials, acute eGFR declines up to 30% were considered acceptable when blood pressure was being brought under control, as the long-term cardiovascular benefits outweighed short-term GFR reduction.[Evidence: B][5] Your doctor interprets your GFR in the context of your overall health picture.
🥗 What to Do With Your Results
If Your GFR Is Normal (≥60 mL/min/1.73m²)
Maintain kidney health through evidence-based lifestyle practices:
- Blood pressure control: Target below 130/80 mmHg per current guidelines
- Blood sugar management: If diabetic, maintain HbA1c below 7%
- Stay hydrated: Drink adequate fluids throughout the day
- Limit sodium: Target less than 2,300 mg daily
- Avoid unnecessary NSAIDs: Ibuprofen and naproxen can affect kidney function with prolonged use
If Your GFR Is Low (<60 mL/min/1.73m²)
Take action based on evidence from screening effectiveness studies. Research shows that high-risk populations benefit significantly from early detection and intervention. Point-of-care eGFR screening detected 38.8% CKD stages 3-5 in patients with diabetes, hypertension, or age over 50, enabling timely intervention.[Evidence: C][8]
Key steps if your GFR is low:
- Confirm the result: Repeat testing in 3 months. CKD requires persistently low GFR.[2]
- Identify the cause: Work with your doctor to determine why GFR is reduced
- Optimize blood pressure and diabetes control: These are the two leading causes of CKD
- Review medications: Some drugs require dose adjustment or should be avoided in CKD
- Consider nephrology referral: Especially if eGFR is below 30 or declining rapidly (>5 mL/min/year)[6]
Monitoring Frequency
How often you need GFR testing depends on your kidney function level and risk factors:
⚖️ GFR vs. Creatinine vs. Cystatin C
Understanding the differences between these kidney markers helps you interpret your results and have informed discussions with your healthcare provider.
| Feature | GFR/eGFR | Creatinine | Cystatin C |
|---|---|---|---|
| What it measures | Kidney filtration rate (calculated) | Muscle breakdown product in blood | Protein produced by all cells |
| How obtained | Calculated from creatinine ± cystatin C | Simple blood test | Simple blood test |
| Accuracy (P30 vs mGFR) | 92.1-94.9%[4] | N/A (raw value) | 89.3%[4] |
| RMSE (mL/min/1.73m²) | 14.5 (combined)[9] | 15.8 (creatinine-based eGFR)[9] | 17.3 (cystatin C-based eGFR)[9] |
| Affected by muscle mass | Yes (when creatinine-based) | Yes, significantly | No |
| Best use case | Routine kidney function assessment | Initial screening, part of metabolic panel | Confirmation when creatinine unreliable[10] |
| Special populations | Most patients | May overestimate GFR in low muscle mass | Better in HIV, cancer, obesity[10] |
| Cost | Included with creatinine test | Low (routine test) | Higher (specialty test) |
The combined creatinine-cystatin C equation provides the best overall accuracy at 94.9% P30 and the lowest error (RMSE 14.5 mL/min/1.73m²).[Evidence: A][4] However, for routine monitoring of stage 3 CKD, creatinine-based eGFR alone is sufficient.[Evidence: A][4] The 2024 KDIGO guidelines recommend reserving combined testing for confirmatory purposes or when creatinine may be unreliable.[Evidence: D][2]
What The Evidence Shows (And Doesn't Show)
What Research Suggests
- High diagnostic accuracy: The combined creatinine-cystatin C equation achieves 94.9% P30 accuracy compared to measured GFR (gold standard) based on meta-analysis of 6,174 patients.[Evidence: A][4]
- Valid CKD classification: eGFR demonstrates 90-95% specificity for CKD classification, meaning few false positives in routine use.[Evidence: B][1]
- Prognostic value established: Each 10 mL/min/1.73m² GFR decline is associated with 15% higher all-cause mortality risk (HR 1.15, 95% CI: 1.04-1.26) over 10+ years of follow-up.[Evidence: C][7]
- Screening effectively detects undiagnosed CKD: Point-of-care eGFR testing identifies 38.8% CKD stages 3-5 in high-risk populations (diabetes, hypertension, age >50).[Evidence: C][8]
- Decline rate predicts outcomes: Rapid GFR decline (>5 mL/min/year) is associated with significantly higher ESRD and mortality risk based on 12+ years of follow-up data.[Evidence: C][6]
What's NOT Yet Proven
- Equation accuracy in children: CKD-EPI 2021 is validated only for adults 18 and older. Pediatric populations require the Schwartz equation.
- Accuracy at extremes of muscle mass: Bodybuilders, amputees, and those with severe muscle wasting may have less accurate creatinine-based eGFR.
- Usefulness in acute kidney injury: eGFR equations assume stable kidney function. In AKI, creatinine lags behind true GFR changes.
- Optimal age-specific thresholds: Whether the fixed eGFR <60 threshold should be adjusted for elderly patients remains under clinical debate (KDIGO 2024 acknowledges this consideration).
- Long-term outcomes of race-free equation: While CKD-EPI 2021 maintains similar accuracy to prior versions, long-term outcome data using the new equation are still accumulating.
Where Caution Is Needed
- Single test interpretation: CKD requires eGFR <60 for >3 months. A single low result may represent acute illness, dehydration, or laboratory variation.[Evidence: D][2]
- Medication dosing in kidney disease: While eGFR guides drug dosing, clinical judgment remains essential. Do not adjust medications based on eGFR alone.[Evidence: B][1]
- Temporary declines during treatment: eGFR drops up to 30% may be acceptable when initiating blood pressure medications. Premature discontinuation may worsen long-term outcomes.[Evidence: B][5]
- Special populations require cystatin C: In HIV, cancer, or obesity, creatinine-based eGFR may be less accurate. Combined equation adds 7.50% accuracy improvement.[Evidence: A][10]
Should YOU Get This Test?
Best suited for: Adults with diabetes, hypertension, family history of kidney disease, age 60 or older, cardiovascular disease, or those taking medications that may affect kidney function. Point-of-care screening in these high-risk groups detects nearly 40% previously undiagnosed CKD.[8]
Not recommended as sole test for: Children under 18 (use Schwartz equation), individuals with rapidly changing kidney function (AKI), or those with extreme muscle mass where creatinine may be unreliable.
Realistic expectations: eGFR provides 90-95% specificity for CKD classification. A single abnormal result should be confirmed with repeat testing at 3 months. Most people with eGFR 45-59 remain stable for years with proper management.
When to consult a professional: If eGFR falls below 60 on any test, if eGFR declines more than 15% between tests, if you have symptoms like fatigue, swelling, or urination changes, or if you have diabetes or hypertension and have never been screened.
Frequently Asked Questions
What does low GFR mean for my overall health?
A persistently low GFR indicates your kidneys are not filtering blood as efficiently as they should. The clinical significance depends on how low your GFR is and how quickly it is declining. Long-term data from the Tehran Lipid and Glucose Study shows that each 10 mL/min decrease in GFR is associated with a 15% higher risk of all-cause mortality (HR 1.15, 95% CI: 1.04-1.26). However, this risk can be modified through proper management of underlying conditions like diabetes and hypertension. Early detection and intervention significantly improve outcomes.
Can my GFR improve, or is kidney damage always permanent?
This depends on the cause. Acute kidney injury (AKI) from dehydration, infections, or medications is often reversible with treatment. Chronic kidney disease (CKD), defined as GFR below 60 for more than 3 months, typically involves permanent structural damage. However, the rate of decline can be slowed significantly. Research shows patients with non-rapid decline (less than 5 mL/min per year) have substantially better long-term outcomes than those with rapid decline. Focus on slowing progression rather than expecting reversal in chronic cases.
What is the difference between GFR and creatinine levels?
Creatinine is a waste product from muscle metabolism that your kidneys filter out of your blood. GFR uses your creatinine level along with your age and sex to calculate how well your kidneys are filtering. The key difference: creatinine is a raw measurement, while GFR is a functional assessment. Two people with the same creatinine level may have different GFRs based on their age, sex, and body composition. GFR provides a more meaningful clinical picture because it accounts for these variables. The CKD-EPI 2021 equation calculates eGFR from creatinine with 92-97% accuracy.
What are the five stages of chronic kidney disease?
CKD stages are based on GFR levels: Stage 1 (eGFR ≥90 with kidney damage), Stage 2 (60-89), Stage 3a (45-59), Stage 3b (30-44), Stage 4 (15-29), and Stage 5 (below 15, kidney failure). Stages 1-2 usually have no symptoms and are detected through screening. Stage 3 may cause fatigue. Stage 4 often produces noticeable symptoms including swelling, nausea, and changes in urination. Stage 5 requires dialysis or transplant to survive. Importantly, CKD diagnosis requires GFR below 60 to persist for at least 3 months, distinguishing it from temporary acute kidney injury.
What should I avoid before a GFR test?
To ensure accurate results, avoid eating cooked meat for 12 hours before your test, as it can temporarily raise creatinine levels. Inform your doctor about all medications, particularly cimetidine, trimethoprim, and certain antibiotics that can affect creatinine. Maintain normal hydration, as dehydration concentrates creatinine. Avoid intense exercise 24 hours before testing, as it can elevate creatinine from muscle breakdown. Fasting is usually not required for a creatinine blood test, but confirm with your provider. These precautions help ensure your eGFR reflects your true kidney function.
What is the CKD-EPI equation used to calculate GFR?
The CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) 2021 equation is the current standard for calculating eGFR. It uses serum creatinine, age, and sex: eGFR = 142 × min(SCr/κ, 1)^α × max(SCr/κ, 1)^-1.200 × 0.9938^Age × 1.012 [if female]. The variables κ and α differ by sex. The 2021 version removed the race coefficient used in earlier equations, recognizing race as a social construct. Validation studies confirm the race-free equation maintains 92-97% accuracy for CKD detection. Your laboratory calculates this automatically when reporting eGFR.
What is normal GFR range by age?
GFR naturally declines with age, approximately 1 mL/min per year after age 40. Typical ranges: ages 20-29: 100-120 mL/min/1.73m²; ages 30-39: 95-115; ages 40-49: 90-110; ages 50-59: 85-105; ages 60-69: 75-95; ages 70+: 60-85. An eGFR of 55 in an 80-year-old without other signs of kidney damage may represent normal aging rather than disease. The 2024 KDIGO guidelines acknowledge this, noting that age-specific interpretation may prevent overdiagnosis in elderly patients. Always interpret GFR in context of age and overall health.
Can diet and lifestyle changes improve kidney function?
While diet cannot reverse established CKD, it can significantly slow progression. Key strategies include: controlling blood pressure below 130/80 mmHg, limiting sodium to under 2,300 mg daily, maintaining adequate protein without excess (0.8 g/kg body weight), and staying well-hydrated. The DISCOVER CKD study showed patients with non-rapid GFR decline had substantially better outcomes. For those with diabetes, blood sugar control (HbA1c below 7%) is essential. Avoiding NSAIDs and smoking cessation also protect kidney function. These interventions work best when started early, before significant kidney damage occurs.
How often should GFR be tested?
Testing frequency depends on your risk level and current kidney function. High-risk individuals (diabetes, hypertension, family history, age 60+) should test annually even with normal GFR. Point-of-care screening effectively identifies undiagnosed CKD in these populations, detecting 38.8% of cases. For established CKD: Stage 3 (eGFR 30-59) requires testing every 6 months; Stage 4 (eGFR 15-29) every 3 months. More frequent testing is needed if GFR is declining rapidly. Your doctor will recommend the appropriate schedule based on your situation.
What medications can affect my GFR test results?
Several medications affect creatinine levels without changing actual kidney function. Trimethoprim (antibiotic) and cimetidine (acid reducer) block creatinine secretion, raising levels and falsely lowering eGFR. Some ACE inhibitors and ARBs may cause expected initial GFR decline when started for blood pressure control. Research shows acute eGFR declines up to 30% may be acceptable during blood pressure management due to long-term cardiovascular benefits. NSAIDs like ibuprofen can reduce kidney blood flow and GFR with prolonged use. Always inform your doctor about all medications before interpreting GFR results.
Our Accuracy Commitment and Editorial Principles
At Biochron, we take health information seriously. Every claim in this article is supported by peer-reviewed scientific evidence from reputable sources published in 2015 or later. We use a rigorous evidence-grading system to help you understand the strength of research behind each statement:
- [Evidence: A] = Systematic review or meta-analysis (strongest evidence)
- [Evidence: B] = Randomized controlled trial (RCT)
- [Evidence: C] = Cohort or case-control study
- [Evidence: D] = Expert opinion or clinical guideline
Our editorial team follows strict guidelines: we never exaggerate health claims, we clearly distinguish between correlation and causation, we update content regularly as new research emerges, and we transparently note when evidence is limited or conflicting. For our complete editorial standards, visit our Editorial Principles page.
This article is for informational purposes only and does not constitute medical advice. Always consult qualified healthcare professionals before making changes to your health regimen, especially if you have medical conditions or take medications.
References
- 1 . Measurement and Estimation of GFR for Use in Clinical Practice: Core Curriculum 2021, Inker LA, Titan S. American Journal of Kidney Diseases, 2021;78(5):736-749. PubMed | DOI [Evidence: B]
- 2 . KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease, Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. Kidney International, 2024;105(4S):S117-S314. PubMed | DOI [Evidence: D]
- 3 . The CKD-EPI 2021 Equation and Other Creatinine-Based Race-Independent eGFR Equations in Chronic Kidney Disease Diagnosis and Staging, Lu S, Robyak K, Zhu Y. The Journal of Applied Laboratory Medicine, 2023;8(5):952-961. PubMed | DOI [Evidence: C]
- 4 . Accuracy of glomerular filtration rate estimation using creatinine and cystatin C for identifying and monitoring moderate chronic kidney disease: the eGFR-C study, Lamb EJ, Barratt J, Brettell EA, et al. Health Technology Assessment, 2024;28(35):1-169. PubMed | DOI [Evidence: A]
- 5 . Acute Declines in Estimated GFR in Blood Pressure Target Trials and Risk of Adverse Outcomes, Ku E, McCulloch CE, Copeland TP, et al. American Journal of Kidney Diseases, 2023;82(4):454-463. PubMed | DOI [Evidence: B]
- 6 . Clinical Outcomes in Patients with CKD and Rapid or Non-rapid eGFR Decline: A Report from the DISCOVER CKD Retrospective Cohort, Heerspink H, Nolan S, Carrero JJ, et al. Advances in Therapy, 2024;41(8):3264-3277. PubMed | DOI [Evidence: C]
- 7 . Kidney function decline is associated with mortality events: over a decade of follow-up from Tehran Lipid and Glucose Study, Masrouri S, Tamehri Zadeh SS, Pishgahi M, et al. Journal of Nephrology, 2024;37(1):107-118. PubMed | DOI [Evidence: C]
- 8 . Community pharmacist-led point-of-care eGFR screening: early detection of chronic kidney disease in high-risk patients, Jairoun AA, Al-Hemyari SS, Shahwan M, et al. Scientific Reports, 2024;14(1):7284. PubMed | DOI [Evidence: C]
- 9 . Accuracy of GFR estimating equations based on creatinine, cystatin C or both in routine care, Fu EL, Levey AS, Coresh J, et al. Nephrology Dialysis Transplantation, 2024;39(4):694-706. PubMed | DOI [Evidence: C]
- 10 . Cystatin C as a GFR Estimation Marker in Acute and Chronic Illness: A Systematic Review, Adingwupu OM, Barbosa ER, Palevsky PM, et al. Kidney Medicine, 2023;5(12):100727. PubMed | DOI [Evidence: A]
Medical Disclaimer
This content is for informational and educational purposes only. It is not intended to provide medical advice or to take the place of such advice or treatment from a personal physician. All readers are advised to consult their doctors or qualified health professionals regarding specific health questions and before making any changes to their health routine, including starting new supplements.
Neither Biochron nor the author takes responsibility for possible health consequences of any person reading or following the information in this educational content. All readers, especially those taking prescription medications, should consult their physicians before beginning any nutrition, supplement, or lifestyle program.
If you have a medical emergency, call your doctor or emergency services immediately.
